USPH Financial Statements From 2010 to 2025

USPH Stock  USD 76.17  0.33  0.43%   
US Physicalrapy financial statements provide useful quarterly and yearly information to potential US Physicalrapy investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on US Physicalrapy financial statements helps investors assess US Physicalrapy's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting US Physicalrapy's valuation are summarized below:
Gross Profit
146.1 M
Profit Margin
0.0473
Market Capitalization
1.2 B
Enterprise Value Revenue
2.109
Revenue
664.4 M
We have found one hundred twenty available fundamental measures for US Physicalrapy, which can be analyzed and compared to other ratios and to its peers in the sector. Traders should compare all of US Physicalrapy latest fundamentals against the fundamentals between 2010 and 2025 to make sure the company is sustainable this year. The US Physicalrapy's current Market Cap is estimated to increase to about 165.1 M. The US Physicalrapy's current Enterprise Value is estimated to increase to about 151.5 M

US Physicalrapy Total Revenue

588.58 Million

Check US Physicalrapy financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among US Physicalrapy's main balance sheet or income statement drivers, such as Interest Expense of 8.4 M, Total Revenue of 588.6 M or Gross Profit of 130.1 M, as well as many indicators such as Price To Sales Ratio of 2.98, Dividend Yield of 0.0195 or PTB Ratio of 4.65. USPH financial statements analysis is a perfect complement when working with US Physicalrapy Valuation or Volatility modules.
  
Check out the analysis of US Physicalrapy Correlation against competitors.
For more detail on how to invest in USPH Stock please use our How to Invest in US Physicalrapy guide.

US Physicalrapy Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets1.2 B1.2 B528.3 M
Slightly volatile
Other Current Liabilities57.3 M54.6 M26.1 M
Slightly volatile
Total Current Liabilities122.1 M116.3 M54.4 M
Slightly volatile
Total Stockholder Equity513.4 M488.9 M242.4 M
Slightly volatile
Property Plant And Equipment Net174.4 M166.1 M66.1 M
Slightly volatile
Accounts Payable6.2 M5.9 MM
Slightly volatile
Cash43.4 M41.4 M30.4 M
Slightly volatile
Non Current Assets Total1.1 BB442.4 M
Slightly volatile
Cash And Short Term Investments43.4 M41.4 M30.4 M
Slightly volatile
Net Receivables89.9 M85.7 M45.6 M
Slightly volatile
Common Stock Shares Outstanding13 M15.1 M12.5 M
Slightly volatile
Liabilities And Stockholders Equity1.2 B1.2 B528.3 M
Slightly volatile
Other Current Assets5.5 M10.6 M9.6 M
Slightly volatile
Other Stockholder Equity274.6 M261.5 M100 M
Slightly volatile
Total Liabilities428.8 M408.4 M175.6 M
Slightly volatile
Property Plant And Equipment Gross265.8 M253.2 M86.2 M
Slightly volatile
Total Current Assets144.5 M137.6 M85.9 M
Slightly volatile
Short and Long Term Debt Total161.3 M153.6 M103.9 M
Slightly volatile
Non Current Liabilities Total306.7 M292.1 M121.3 M
Slightly volatile
Short Term Debt53.4 M50.8 M23.8 M
Slightly volatile
Intangible Assets188.3 M179.3 M63 M
Slightly volatile
Good Will633.8 M667.2 M922.3 T
Slightly volatile
Common Stock Total Equity144.3 K173.7 K141.6 K
Slightly volatile
Common Stock148.6 K197.8 K144.8 K
Slightly volatile
Other Assets2.1 M1.9 M2.3 M
Pretty Stable
Long Term Debt149.7 M142.5 M69.3 M
Slightly volatile
Property Plant Equipment154.3 M146.9 M53.8 M
Slightly volatile
Current Deferred Revenue1.9 M3.3 M2.7 M
Very volatile
Other Liabilities41.5 M39.5 M15.4 M
Slightly volatile
Long Term Debt Total142 M135.2 M65.3 M
Slightly volatile
Capital Surpluse73.5 M118.1 M71.6 M
Slightly volatile
Non Current Liabilities Other19.2 M18.3 M5.8 M
Slightly volatile
Warrants106 M178.6 M87.1 M
Slightly volatile
Short and Long Term Debt11.5 M11 M3.5 M
Slightly volatile
Net Invested Capital452.3 M642.5 M350.1 M
Slightly volatile
Capital Stock172.4 K197.8 K155.4 K
Slightly volatile
Capital Lease Obligations118.5 M141.7 M96.6 M
Slightly volatile

US Physicalrapy Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Total Revenue588.6 M560.6 M395.1 M
Slightly volatile
Gross Profit130.1 M123.9 M88.9 M
Slightly volatile
Other Operating Expenses522.2 M497.3 M342.4 M
Slightly volatile
Cost Of Revenue458.5 M436.6 M306.2 M
Slightly volatile
Total Operating Expenses63.7 M60.7 M36.2 M
Slightly volatile
Income Tax ExpenseM14.6 M11.4 M
Slightly volatile
Depreciation And Amortization19.6 M18.7 M10.4 M
Slightly volatile
Income Before Tax33 M60.2 M46.8 M
Slightly volatile
Selling General Administrative62.7 M59.7 M37.9 M
Slightly volatile
Net Income Applicable To Common Shares19.8 M33.7 M25.3 M
Slightly volatile
Net Income From Continuing Ops42.9 M45.6 M38.6 M
Slightly volatile
Non Recurring4.7 M4.9 M4.3 M
Slightly volatile
Non Operating Income Net Other2.3 M2.9 M2.4 M
Pretty Stable
Tax Provision13.6 M14.6 M12.8 M
Very volatile
Interest Income4.1 M3.9 M3.5 M
Slightly volatile
Reconciled Depreciation13.8 M18.7 M11.4 M
Slightly volatile
Extraordinary Items3.4 M3.9 M4.2 M
Slightly volatile
Selling And Marketing Expenses7.6 M8.6 M9.3 M
Slightly volatile

US Physicalrapy Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Capital Expenditures5.5 M9.2 M6.5 M
Slightly volatile
End Period Cash Flow43.4 M41.4 M30.4 M
Slightly volatile
Begin Period Cash Flow160.5 M152.8 M35.7 M
Slightly volatile
Depreciation19.6 M18.7 M10 M
Slightly volatile
Stock Based Compensation4.7 M7.8 M5.2 M
Slightly volatile
Dividends Paid27.9 M26.5 M13 M
Slightly volatile
Change To Netincome39.9 M38 M19.4 M
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio2.982.38393.7415
Slightly volatile
Dividend Yield0.01950.01990.0163
Slightly volatile
PTB Ratio4.652.73324.2348
Very volatile
Days Sales Outstanding62.3355.780842.3877
Very volatile
Book Value Per Share52.9150.388126.3548
Slightly volatile
Stock Based Compensation To Revenue0.00920.0140.0123
Slightly volatile
Capex To Depreciation0.470.49170.7267
Slightly volatile
PB Ratio4.652.73324.2348
Very volatile
EV To Sales2.892.58423.6785
Slightly volatile
ROIC0.04130.04340.0998
Slightly volatile
Payables Turnover88.1973.5566124
Very volatile
Sales General And Administrative To Revenue0.120.09880.0992
Slightly volatile
Capex To Revenue0.01560.01640.037
Slightly volatile
Cash Per Share2.882.74582.2896
Slightly volatile
Payout Ratio1.051.0030.5852
Slightly volatile
Days Payables Outstanding5.34.96224.5266
Slightly volatile
Income Quality2.191.64341.6317
Slightly volatile
Intangibles To Total Assets0.760.7250.6606
Slightly volatile
Net Debt To EBITDA1.361.29161.3751
Very volatile
Current Ratio1.121.18322.4644
Slightly volatile
Receivables Turnover5.826.54358.8041
Slightly volatile
Graham Number37.6135.815327.8149
Slightly volatile
Shareholders Equity Per Share34.0832.456818.1902
Slightly volatile
Debt To Equity0.480.31420.3794
Slightly volatile
Capex Per Share0.330.60980.5013
Slightly volatile
Revenue Per Share39.0737.211430.1883
Slightly volatile
Interest Debt Per Share11.2710.72898.1445
Slightly volatile
Debt To Assets0.220.13160.1802
Slightly volatile
Short Term Coverage Ratios1.41.474236.1477
Slightly volatile
Operating Cycle62.2555.780842.2349
Pretty Stable
Price Book Value Ratio4.652.73324.2348
Very volatile
Days Of Payables Outstanding5.34.96224.5266
Slightly volatile
Dividend Payout Ratio1.051.0030.5852
Slightly volatile
Pretax Profit Margin0.0880.10740.1235
Slightly volatile
Ebt Per Ebit0.660.95250.9497
Slightly volatile
Effective Tax Rate0.330.24260.2696
Slightly volatile
Company Equity Multiplier1.492.38781.9345
Slightly volatile
Long Term Debt To Capitalization0.260.17370.2218
Slightly volatile
Total Debt To Capitalization0.280.23910.2553
Slightly volatile
Debt Equity Ratio0.480.31420.3794
Slightly volatile
Quick Ratio1.121.18322.4664
Slightly volatile
Net Income Per E B T0.640.43950.5339
Slightly volatile
Cash Ratio0.340.35571.1465
Slightly volatile
Days Of Sales Outstanding62.3355.780842.3877
Very volatile
Free Cash Flow Operating Cash Flow Ratio0.960.87740.9363
Slightly volatile
Price To Book Ratio4.652.73324.2348
Very volatile
Fixed Asset Turnover3.213.375311.6148
Slightly volatile
Debt Ratio0.220.13160.1802
Slightly volatile
Price Sales Ratio2.982.38393.7415
Slightly volatile
Asset Turnover0.460.48010.8893
Slightly volatile
Gross Profit Margin0.290.22110.2302
Very volatile
Price Fair Value4.652.73324.2348
Very volatile

US Physicalrapy Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap165.1 M157.2 M163.1 M
Slightly volatile
Enterprise Value151.5 M144.3 M149.6 M
Slightly volatile

USPH Fundamental Market Drivers

Forward Price Earnings31.8471
Cash And Short Term Investments41.4 M

USPH Upcoming Events

28th of February 2024
Upcoming Quarterly Report
View
1st of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
28th of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About US Physicalrapy Financial Statements

Investors use fundamental indicators, such as US Physicalrapy's revenue or net income, to determine how well the company is positioned to perform in the future. Although US Physicalrapy's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last ReportedProjected for Next Year
Current Deferred Revenue3.3 M1.9 M
Total Revenue560.6 M588.6 M
Cost Of Revenue436.6 M458.5 M
Stock Based Compensation To Revenue 0.01  0.01 
Sales General And Administrative To Revenue 0.10  0.12 
Capex To Revenue 0.02  0.02 
Revenue Per Share 37.21  39.07 
Ebit Per Revenue 0.11  0.07 

Currently Active Assets on Macroaxis

When determining whether US Physicalrapy offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of US Physicalrapy's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Us Physicalrapy Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Us Physicalrapy Stock:
Check out the analysis of US Physicalrapy Correlation against competitors.
For more detail on how to invest in USPH Stock please use our How to Invest in US Physicalrapy guide.
You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of US Physicalrapy. If investors know USPH will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about US Physicalrapy listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.24)
Dividend Share
1.76
Earnings Share
1.84
Revenue Per Share
44.107
Quarterly Revenue Growth
0.166
The market value of US Physicalrapy is measured differently than its book value, which is the value of USPH that is recorded on the company's balance sheet. Investors also form their own opinion of US Physicalrapy's value that differs from its market value or its book value, called intrinsic value, which is US Physicalrapy's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because US Physicalrapy's market value can be influenced by many factors that don't directly affect US Physicalrapy's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between US Physicalrapy's value and its price as these two are different measures arrived at by different means. Investors typically determine if US Physicalrapy is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, US Physicalrapy's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.